Tag Archives: Essi Tuominen
Low-dose naltrexone in the treatment of ME/CFS
Low-dose naltrexone in the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), by Olli Polo, Pia Pesonen, Essi Tuominen in Fatigue: Biomedicine, Health & Behavior Nov 19, 2019 [doi/full/10.1080/21641846.2019.1692770] Research abstract: Background: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is … Continue reading
Posted in News
Tagged drug safety, Essi Tuominen, LDN, low dose naltrexone, Olli Polo, Pia Pesonen
Comments Off on Low-dose naltrexone in the treatment of ME/CFS
